Evidence method
Level · gp.fundamentals.capex_revenue_ratio
0.22% · OPTIONAL · VALID
GROSSPATTERN / FUNDAMENTAL STATE / POINT IN TIME
CPIX · Jun 30, 2017
CUMBERLAND PHARMACEUTICALS INC. A multidimensional configuration derived from the filing available at this observation—never a composite score or recommendation.
STATE CAPABILITYLEVEL 3[email protected]
Inspectable configuration
State dimensions
Filing0001628280-17-008470General Corporate
Evidence method
Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
-29.20% · OPTIONAL · VALID
Evidence method
Yoy · gp.fundamentals.revenue
16.89% · CORE · VALID
Evidence method
Level · gp.fundamentals.inventory_revenue_ratio
64.08% · OPTIONAL · VALID
Evidence method
Level · gp.fundamentals.gross_margin
80.74% · CORE · VALID
Evidence method
Level · gp.fundamentals.operating_margin
-19.39% · CORE · VALID
Evidence method
Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
12.47% · OPTIONAL · VALID
Evidence method
Level · gp.fundamentals.sbc_revenue_ratio
3.42% · OPTIONAL · VALID
As-filed lineage
Fundamental state history
Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History61 statesSelf-history eligible
Sep 30, 20217/7 normalizedLevel 3Dec 31, 20218/8 normalizedLevel 3Mar 31, 20228/8 normalizedLevel 3Jun 30, 20228/8 normalizedLevel 3Sep 30, 20228/8 normalizedLevel 3Dec 31, 20228/8 normalizedLevel 3Mar 31, 20238/8 normalizedLevel 3Jun 30, 20238/8 normalizedLevel 3Sep 30, 20238/8 normalizedLevel 3Dec 31, 20238/8 normalizedLevel 3Mar 31, 20248/8 normalizedLevel 3Jun 30, 20248/8 normalizedLevel 3Sep 30, 20248/8 normalizedLevel 3Dec 31, 20248/8 normalizedLevel 3Mar 31, 20258/8 normalizedLevel 3Jun 30, 20258/8 normalizedLevel 3Sep 30, 20258/8 normalizedLevel 3Dec 31, 20258/8 normalizedLevel 3Mar 31, 20268/8 normalizedLevel 3Jun 30, 20264/4 normalizedLevel 4
Period transition
What moved in the state?
- Previous
- 1.29%
- Current
- 0.22%
- Delta
- -1.06%
- Previous
- 14.94%
- Current
- -29.20%
- Delta
- -44.13%
- Previous
- 24.55%
- Current
- 16.89%
- Delta
- -7.66%
- Previous
- 58.60%
- Current
- 64.08%
- Delta
- 5.49%
- Previous
- 85.66%
- Current
- 80.74%
- Delta
- -4.92%
- Previous
- -6.83%
- Current
- -19.39%
- Delta
- -12.57%
- Previous
- 9.32%
- Current
- 12.47%
- Delta
- 3.14%
- Previous
- 2.64%
- Current
- 3.42%
- Delta
- 0.78%
Self-history only
Previous similar states
Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research
Transitioned To · CPIX Fundamental State →Transitioned To · CPIX Fundamental State →Transitioned To · CPIX CAPEX_INTENSITY_DECREASED →Transitioned To · CPIX CASH_GENERATION_DECREASED →Transitioned To · CPIX GROWTH_DECREASED →Transitioned To · CPIX INVENTORY_PRESSURE_INCREASED →Transitioned To · CPIX MARGIN_DECREASED →Transitioned To · CPIX PROFITABILITY_DECREASED →Transitioned To · CPIX R_AND_D_INTENSITY_INCREASED →Transitioned To · CPIX SBC_INTENSITY_INCREASED →
Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.